THE HYDRATION PHARMACEUTICALS CO ORD
Hydralyte North America reaches sales milestone on Amazon USA, Canadian market penetration surges
As part of its ongoing US expansion, The Hydration Pharmaceuticals Company (ASX: HPC), which trades as Hydralyte North America, has achieved a major sales milestone on Amazon USA, while revenue growth in Canada has surged in recent weeks. Hydralyte North America has developed and sells a range of Hydralyte products, which it describes as “healthy […]
Hydralyte North America launches Shay Mitchell co-branded rehydration product
The Hydration Pharmaceuticals Company (ASX: HPC) trading as Hydralyte North America has successfully launched a co-branded rehydration product with renowned actress Shay Mitchell. Ms Mitchell was engaged as Hydralyte North America’s brand ambassador in March this year and today’s co-branded stockkeeping unit (SKU) product launch follows an “extensive period of collaboration”. The collaboration involved flavour […]
Hydralyte North America gains regulatory approvals for Canadian market
The Hydration Pharmaceuticals Company Limited (ASX: HPC) (trading as Hydralyte North America) has secured regulatory approvals from Health Canada for the manufacture of liquid products destined for the Canadian market. The approvals will allow the company to optimise its manufacturing processes from a centralised hub and capitalise on its existing distribution channels across North America. […]
Hydralyte North America reports strong quarterly sales fuelled by Canadian heatwave
A net sales revenue of US$2.44 million has delivered another quarter of strong growth for The Hydration Pharmaceuticals Company (ASX: HPC), trading as Hydralyte North America. Revenue figures for the three months to the end of September represent a 17% increase on the US$2.08 million reported for the previous corresponding period. The result was fuelled […]